NCT06645301View on ClinicalTrials.gov

BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions
Colorectal CancerPancreatic Cancer
Interventions
BIOLOGICAL

Group A

BGT007 3.0×10\^8cells,Intravenous infusion，3 subject is planned to be enrolled

BIOLOGICAL

Group B

BGT007 6.0×10\^8cells,Intravenous infusion，6 subject is planned to be enrolled

All Listed Sponsors
collaborator

South China Hospital of Shenzhen University

UNKNOWN

lead

BioSyngen Pte Ltd

INDUSTRY